Jul 13, 2026 06:53AM
Jul 10, 2026 02:10PM
Jul 10, 2026 02:10PM
Jun 24, 2026 08:15AM
Jun 24, 2026 08:15AM
Jun 24, 2026 06:45AM
Jun 24, 2026 06:45AM European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resect
Jun 23, 2026 09:30AM
Jun 11, 2026 06:45AM
Jun 11, 2026 06:45AM
Jun 2, 2026 06:48AM
May 22, 2026 07:55AM
May 22, 2026 07:55AM
May 13, 2026 08:30AM Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 12, 2026 06:45AM
May 12, 2026 06:45AM
May 6, 2026 09:00AM
May 5, 2026 08:45AM
May 5, 2026 08:45AM
May 1, 2026 01:15PM
Apr 30, 2026 06:45AM Merck beats estimates on strong oncology sales; shares up 4% in pre-market trade
Apr 30, 2026 06:31AM
Apr 30, 2026 06:30AM
Apr 24, 2026 06:45AM
Apr 24, 2026 06:45AM
Apr 7, 2026 09:38AM
Apr 7, 2026 09:04AM
Apr 7, 2026 09:00AM Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
Mar 30, 2026 04:31PM
Mar 27, 2026 08:50AM
Mar 26, 2026 06:57AM
Mar 25, 2026 04:09PM
Mar 25, 2026 12:24PM
Mar 25, 2026 10:30AM
Mar 25, 2026 10:13AM H.C. Wainwright Downgrades Terns Pharmaceuticals (TERN) to Neutral
Mar 25, 2026 09:34AM
Mar 25, 2026 08:12AM
Mar 25, 2026 07:39AM
Mar 25, 2026 07:02AM
Mar 25, 2026 06:45AM
Mar 25, 2026 06:45AM
Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
Feb 12, 2026 06:45AM
Feb 12, 2026 06:45AM
Feb 4, 2026 05:48AM
Feb 3, 2026 06:48AM
Feb 3, 2026 06:30AM
Jan 26, 2026 08:43AM
Jan 25, 2026 02:35PM Merck ends acquisition talks with Revolution Medicines - WSJ
Jan 20, 2026 06:21AM

1,167,458 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All